These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 17354160)

  • 1. Clinical and bacteriological outcome of different doses and duration of pivmecillinam compared with placebo therapy of uncomplicated lower urinary tract infection in women: the LUTIW project.
    Ferry SA; Holm SE; Stenlund H; Lundholm R; Monsen TJ
    Scand J Prim Health Care; 2007 Mar; 25(1):49-57. PubMed ID: 17354160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mecillinam resistance and outcome of pivmecillinam treatment in uncomplicated lower urinary tract infection in women.
    Monsen TJ; Holm SE; Ferry BM; Ferry SA
    APMIS; 2014 Apr; 122(4):317-23. PubMed ID: 24738161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and bacteriological efficacy of pivmecillinam treatment for uncomplicated urinary tract infections caused by ESBL-producing Escherichia coli: a prospective, multicentre, observational cohort study.
    Bollestad M; Grude N; Solhaug S; Raffelsberger N; Handal N; Nilsen HS; Romstad MR; Emmert A; Tveten Y; Søraas A; Jenum PA; Jenum S; Møller-Stray J; Weme ET; Lindbaek M; Simonsen GS;
    J Antimicrob Chemother; 2018 Sep; 73(9):2503-2509. PubMed ID: 29982514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The natural course of uncomplicated lower urinary tract infection in women illustrated by a randomized placebo controlled study.
    Ferry SA; Holm SE; Stenlund H; Lundholm R; Monsen TJ
    Scand J Infect Dis; 2004; 36(4):296-301. PubMed ID: 15198188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of pivmecillinam: 3 days or 5 days t.i.d against community acquired uncomplicated lower urinary tract infections - a randomized, double-blinded, placebo-controlled clinical trial study protocol.
    Jansåker F; Frimodt-Møller N; Bjerrum L; Dahl Knudsen J
    BMC Infect Dis; 2016 Dec; 16(1):727. PubMed ID: 27905884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pivmecillinam versus sulfamethizole for short-term treatment of uncomplicated acute cystitis in general practice: a randomized controlled trial.
    Bjerrum L; Gahrn-Hansen B; Grinsted P
    Scand J Prim Health Care; 2009; 27(1):6-11. PubMed ID: 18991182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A general practice evaluation of pivmecillinam given twice daily as a treatment for acute urinary tract infection.
    Skinner JL; Venables TL; Sheldon MG
    Pharmatherapeutica; 1984; 4(1):25-31. PubMed ID: 6504945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment duration of pivmecillinam in men, non-pregnant and pregnant women for community-acquired urinary tract infections caused by Escherichia coli: a retrospective Danish cohort study.
    Boel JB; Jansåker F; Hertz FB; Hansen KH; Thønnings S; Frimodt-Møller N; Knudsen JD
    J Antimicrob Chemother; 2019 Sep; 74(9):2767-2773. PubMed ID: 31098630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of pivmecillinam and cephradine in bacteriuria in pregnancy and in acute urinary tract infection.
    Brumfitt W; Franklin I; Hamilton-Miller J; Anderson F
    Scand J Infect Dis; 1979; 11(4):275-9. PubMed ID: 231299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ibuprofen versus pivmecillinam for uncomplicated urinary tract infection in women-A double-blind, randomized non-inferiority trial.
    Vik I; Bollestad M; Grude N; Bærheim A; Damsgaard E; Neumark T; Bjerrum L; Cordoba G; Olsen IC; Lindbæk M
    PLoS Med; 2018 May; 15(5):e1002569. PubMed ID: 29763434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open, multi-centre evaluation of a 5-day course of pivmecillinam in urinary tract infections in general practice.
    Place C
    Pharmatherapeutica; 1981; 3(1):55-60. PubMed ID: 6275417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli.
    Ejrnæs K
    Dan Med Bull; 2011 Apr; 58(4):B4187. PubMed ID: 21466767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of pivmecillinam and cephalexin in acute uncomplicated urinary tract infection.
    Menday AP
    Int J Antimicrob Agents; 2000 Jan; 13(3):183-7. PubMed ID: 10724022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pivmecillinam plus pivampicillin in complicated urinary tract infection. Double-blind comparison of the combination pivmecillinam/pivampicillin and pivmecillinam alone in patients with urinary tract infection.
    Frimodt-Møller C; Vejlsgaard R
    J Int Med Res; 1981; 9(4):283-7. PubMed ID: 6266897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three days of pivmecillinam or norfloxacin for treatment of acute uncomplicated urinary infection in women.
    Nicolle LE; Madsen KS; Debeeck GO; Blochlinger E; Borrild N; Bru JP; Mckinnon C; O'Doherty B; Spiegel W; Van Balen FA; Menday P
    Scand J Infect Dis; 2002; 34(7):487-92. PubMed ID: 12195873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptomatic vaginal candidiasis after pivmecillinam and norfloxacin treatment of acute uncomplicated lower urinary tract infection.
    Menday AP
    Int J Antimicrob Agents; 2002 Oct; 20(4):297-300. PubMed ID: 12385688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pivmecillinam in the treatment of urinary tract infections.
    Nicolle LE
    J Antimicrob Chemother; 2000 Sep; 46 Suppl 1():35-9; discussion 63-5. PubMed ID: 11051622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of three days' therapy with cefcanel or amoxicillin for the treatment of acute uncomplicated urinary tract infection.
    Nicolle LE; Hoepelman AI; Floor M; Verhoef J; Norgard K
    Scand J Infect Dis; 1993; 25(5):631-7. PubMed ID: 8284649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of pivmecillinam for treatment of lower urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
    Titelman E; Iversen A; Kalin M; Giske CG
    Microb Drug Resist; 2012 Apr; 18(2):189-92. PubMed ID: 22204597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal dosage and duration of pivmecillinam treatment for uncomplicated lower urinary tract infections: a systematic review and meta-analysis.
    Pinart M; Kranz J; Jensen K; Proctor T; Naber K; Kunath F; Wagenlehner F; Schmidt S
    Int J Infect Dis; 2017 May; 58():96-109. PubMed ID: 28341436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.